Section Arrow
ETON.NASDAQ
- Eton Pharmaceuticals
Quotes are at least 15-min delayed:2025/12/26 23:04 EST
Regular Hours
Last
 16.83
-0.16 (-0.94%)
Day High 
17.33 
Prev. Close
16.99 
1-M High
17.3 
Volume 
140.73K 
Bid
16.27
Ask
20
Day Low
16.65 
Open
16.98 
1-M Low
15.28 
Market Cap 
455.63M 
Currency 美元 
P/E 124 
%Yield -- 
10-SMA 16.38 
20-SMA 16.28 
50-SMA 17.19 
52-W High 23 
52-W Low 11.0867 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.26/1.17
Enterprise Value
485.55M
Balance Sheet
Book Value Per Share
0.86
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
39.01M
Operating Revenue Per Share
1.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CGCCanopy Growth Corp1.19-0.12-9.16%-- 
HIMSHims & Hers Health34.31-0.36-1.04%65.13PE
IXHLIncannex Healthcare0.3988-0.0118-2.87%-- 
TLRYTilray Brands Inc.9.6-0.55-5.42%-- 
DVAXDynavax Technologies Corp15.38----48.45PE
Industry overview quotes are at least 15 minutes delayed
Business Description
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.